A fusion model based on tumor and peritumoral CT radiomics for differentiating bronchiolar adenoma from lung adenocarcinoma
Frontiers in Oncology · 15.04.2026 · 16
DOI: 10.3389/fonc.2026.1798218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 15.04.2026. Verfasst von Ziqian Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical imaging, the First Affiliated Hospital of Kunming Medical University, Kunming, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This study aimed to develop and validate a combined clinical and tumor–peritumoral CT radiomics model to differentiate bronchiolar adenoma (BA) from lung adenocarcinoma (LUAD), thereby improving preoperative diagnostic accuracy and guiding individualized treatment strategies.
Methods
A total of 362 patients with pathologically confirmed BA or LUAD were retrospectively analyzed. Data from Medical Center 1 (n = 281) were divided into training and test sets (7:3 ratio), and data from Medical Center 2 (n = 81) served as an external validation set. Clinical characteristics, CT morphological features, and tumor–peritumoral radiomics features were extracted. Five machine learning algorithms were applied to construct and compare predictive models.
Results
Lung lobe distribution, density, vacuolar sign, tumor-associated vessels, distance to pleura, and nodule diameters differed significantly between BA and LUAD. Among radiomics models, the tumor–peritumoral MLP model achieved the best performance (AUCs: 0.918, 0.912, 0.888). The clinical–radiomics fusion model outperformed single models, with AUCs of 0.935, 0.939, and 0.910 and accuracies of 0.862, 0.847, and 0.864 in the training, test, and validation sets, respectively.
Conclusion
The proposed fusion model enables accurate, non-invasive differentiation between BA and LUAD, offering valuable support for personalized clinical decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical imaging, the First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Department of Medical imaging, Second people's Hospital of Qujing City, Qujing, China.
- Department of Radiology, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
- Department of first Thoracic Surgery, the First Affiliated Hospital of Kunming Medical University, Kunming, China.
Zitieren
APA
Zhao, Z., Ke, T., Xu, Z., Zhou, Y., Dong, Y., Liu, Y., Wu, J., Wei, W., Han, D., & Zhao, W. (2026). A fusion model based on tumor and peritumoral CT radiomics for differentiating bronchiolar adenoma from lung adenocarcinoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1798218
Vancouver
Zhao Z, Ke T, Xu Z, Zhou Y, Dong Y, Liu Y, et al. A fusion model based on tumor and peritumoral CT radiomics for differentiating bronchiolar adenoma from lung adenocarcinoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1798218
BibTeX
@article{Zhao2026,
author = {Zhao, Ziqian and Ke, Tengfei and Xu, Zeyan and Zhou, Yong and Dong, Yanwen and Liu, Yifan and Wu, Jianping and Wei, Wenyan and Han, Dan and Zhao, Wen},
title = {A fusion model based on tumor and peritumoral CT radiomics for differentiating bronchiolar adenoma from lung adenocarcinoma},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1798218}
}
EUVIMED